Tracy M. Downs, MD, FACS close
Tracy M. Downs, MD, FACS

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Tracy M. Downs, MD, FACS Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Downs is a urologic surgeon and fellowship-trained specialist in urologic oncology. He performs specialized surgery for complex cancers of the genitourinary tract, including robotic cystectomy and other minimally invasive procedures. He has a special interest in the treatment of bladder cancer, and directs the UW Bladder Cancer and Intravescial Therapy Programs. 



Bladder Cancer


Genitourinary Cancer (Bladder, Kidney, Prostate, Testicular)

Kidney Cancer

Minimally Invasive Surgery


Orthotopic Neobladder

Prostate Brachytherapy


Robotic Cystectomy

Robotic Prostatectomy

Testicular Cancer


Urinary Reconstruction Surgery



1 S. Park Clinic
(608) 287-2900 | (888) 703-2778 | Map
University Hospital
(608) 263-4757 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Urology

Professional Certifications and Education

Board Certification Urology
Fellowship Urologic Oncology, University of California San Francisco Medical Center, San Francisco, CA, 2003
Residency Brigham and Women's Hospital, Boston, MA
Medical School University of California, San Diego School of Medicine, La Jolla, CA

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Dr. Downs has a joint appointment with the UW Carbone Cancer Center where his translational research focuses on discovery of molecular and urinary biomarkers for bladder cancer and his clinical research focuses on developing new therapies for genitourinary cancers.

PubMed Articles
Posielski NM Richards KA Liou JI Borza T Abel EJ Downs TM Jarrard DF Beta-Adrenergic Antagonists and Cancer Specific Survival in Patients with Advanced Prostate Cancer: A Veterans Administration Cohort Study. Urology . 2021 Feb 12;
[PubMed ID: 33587939]
Boorjian SA Alemozaffar M Konety BR Shore ND Gomella LG Kamat AM Bivalacqua TJ Montgomery JS Lerner SP Busby JE Poch M Crispen PL Steinberg GD Schuckman AK Downs TM Svatek RS Mashni J Jr Lane BR Guzzo TJ Bratslavsky G Karsh LI Woods ME Brown G Canter D Luchey A Lotan Y Krupski T Inman BA Williams MB Cookson MS Keegan KA Andriole GL Jr Sankin AI Boyd A O'Donnell MA Sawutz D Philipson R Coll R Narayan VM Treasure FP Yla-Herttuala S Parker NR Dinney CPN Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol . 2021 Jan;22(1):107-117
[PubMed ID: 33253641]
Downs TM Enemchukwu E Lee CT Moses KA Nyame YA Powell IJ Vince R Williams H Wilson S Washington SL Supporting Black voices in urology. Nat Rev Urol . 2021 Jan;18(1):7-17
[PubMed ID: 33318668]
Vuong I Wright J Nolan MB Eggen A Bailey E Strickland R Traynor A Downs T Overcoming Barriers: Evidence-Based Strategies to Increase Enrollment of Underrepresented Populations in Cancer Therapeutic Clinical Trials-a Narrative Review. J Cancer Educ . 2020 Oct;35(5):841-849
[PubMed ID: 31713103]
Barocas DA Boorjian SA Alvarez RD Downs TM Gross CP Hamilton BD Kobashi KC Lipman RR Lotan Y Ng CK Nielsen ME Peterson AC Raman JD Smith-Bindman R Souter LH Microhematuria: AUA/SUFU Guideline. J Urol . 2020 Oct;204(4):778-786
[PubMed ID: 32698717]
Lee CT Mohamed NE Pisipati S Shah QN Agarwal PK Downs TM Droller M Gilbert SM Goltz HH Hall SJ Hendawi M Hoffman-Censits J O'Donnell M Kaag M Karsh LI Kassouf W Quale DZ Sagalowsky A Steinberg GD Latini DM Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach. BMC Health Serv Res . 2020 Jul 24;20(1):686
[PubMed ID: 32709234]
Flaig TW Spiess PE Agarwal N Bangs R Boorjian SA Buyyounouski MK Chang S Downs TM Efstathiou JA Friedlander T Greenberg RE Guru KA Guzzo T Herr HW Hoffman-Censits J Hoimes C Inman BA Jimbo M Kader AK Lele SM Michalski J Montgomery JS Nandagopal L Pagliaro LC Pal SK Patterson A Plimack ER Pohar KS Preston MA Sexton WJ Siefker-Radtke AO Tward J Wright JL Gurski LA Johnson-Chilla A Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw . 2020 Mar;18(3):329-354
[PubMed ID: 32135513]
Miller BL Abel EJ Allen G Schumacher JR Jarrard D Downs T Richards KA Trends in epidural anesthesia use at the time of radical cystectomy and its association with perioperative and survival outcomes: a population-based analysis. Am J Clin Exp Urol . 2020;8(1):28-37
[PubMed ID: 32211451]
Shapiro DD Wells SA Best SL Hedican SP Ziemlewicz TJ Lubner MG Hinshaw JL Lee FT Jr Jarrard DF Richards KA Downs TM Allen GO Nakada SY Abel EJ Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery. Urology . 2020 Jan;135:88-94
[PubMed ID: 31585198]
Ravvaz K Weissert JA Downs TM American Urological Association Nonmuscle Invasive Bladder Cancer Risk Model Validation-Should Patient Age be Added to the Risk Model? J Urol . 2019 Oct;202(4):682-688
[PubMed ID: 31188732]
Lotan Y Bivalacqua TJ Downs T Huang W Jones J Kamat AM Konety B Malmström PU McKiernan J O'Donnell M Patel S Pohar K Resnick M Sankin A Smith A Steinberg G Trabulsi E Woods M Daneshmand S Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018. Nat Rev Urol . 2019 Jun;16(6):377-386
[PubMed ID: 31019310]
Wang JH Sierra P Richards KA Abel EJ Allen GO Downs TM Jarrard DF Impact of bilateral biopsy-detected prostate cancer on an active surveillance population. BMC Urol . 2019 Apr 23;19(1):26
[PubMed ID: 31014300]
Etheridge T Liou JI Downs TM Abel EJ Jarrard DF Richards KA The Impact of Agent Orange Exposure on Prostate Cancer Outcomes. J Urol . 2019 Apr;201(4):742-750
[PubMed ID: 30321553]
Anderson-Carter I Posielski N Liou JI Khemees TA Downs TM Abel EJ Jarrard DF Richards KA The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study. Urol Oncol . 2019 Feb;37(2):130-137
[PubMed ID: 30528885]
Smith AB Daneshmand S Patel S Pohar K Trabulsi E Woods M Downs T Huang W Taylor J Jones J O'Donnell M Bivalacqua T DeCastro J Steinberg G Kamat A Resnick M Konety B Schoenberg M Jones JS Lotan Y Flexible Blue Light Study Group Collaborators. Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study. BJU Int . 2019 Jan;123(1):35-41
[PubMed ID: 29979488]
Richards KA Liou JI Cryns VL Downs TM Abel EJ Jarrard DF Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy. J Urol . 2018 Dec;200(6):1256-1263
[PubMed ID: 29940252]
Downs TM Weissert JA Ravvaz K Can We Improve Nonmuscle Invasive Bladder Cancer Guideline Adherence With Smarter Risk Stratification? J Urol . 2018 Oct;200(4):706-708
[PubMed ID: 29906436]
Flaig TW Spiess PE Agarwal N Bangs R Boorjian SA Buyyounouski MK Downs TM Efstathiou JA Friedlander T Greenberg RE Guru KA Hahn N Herr HW Hoimes C Inman BA Jimbo M Kader AK Lele SM Meeks JJ Michalski J Montgomery JS Pagliaro LC Pal SK Patterson A Petrylak DP Plimack ER Pohar KS Porter MP Preston MA Sexton WJ Siefker-Radtke AO Tward J Wile G Johnson-Chilla A Dwyer MA Gurski LA NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. J Natl Compr Canc Netw . 2018 Sep;16(9):1041-1053
[PubMed ID: 30181416]
Washington SL 3rd Baradaran N Gaither TW Awad MA Murphy GP Downs TM Breyer BN Racial distribution of urology workforce in United States in comparison to general population. Transl Androl Urol . 2018 Aug;7(4):526-534
[PubMed ID: 30211043]
Maciolek KA Best SL Lopez V Posielski N Knoedler M Bushman WA Jarrard DF Downs TM Abel EJ Richards KA Effectiveness of a transrectal prostate needle biopsy protocol with risk-tailored antimicrobials in a veterans cohort. Urol Oncol . 2018 Aug;36(8):363.e13-363.e20
[PubMed ID: 29887242]